Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Access Dialogues

The Access Dialogue Series is a multi-stakeholder cross-sectoral platform for sharing information and best practices as well as discussing collaborative action around barriers to access challenges with public and private stakeholders. We are sponsoring these access dialogues not as a one-off event, but rather as a platform for a continuous and creative dialogue and exchange amongst all stakeholders on priority access topics and challenges. We engage and collaborate with our partners including multilateral organizations, governments, nongovernmental organizations, civil society, foundations, research institutions and academia, health care professional associations, patient organizations, think tanks and private sector partners.
The purpose of the Access Dialogues is threefold: 
  1. to collaboratively identify creative potential opportunities to leverage the core competencies of the company towards further engagement in access initiatives;
  2. through an expert panel and discussion will focus on the different challenges and options around innovative approaches to access;
  3. raise awareness and educate internally on global health and access to challenges to foster the mindset of making A2H a part of Merck, KGaA, Darmstadt, Germany's DNA, as well as externally to raise visibility on key barriers to access.
Merck, KGaA, Darmstadt, Germany Innovative Access and Intellectual Property (IP) Access Dialogue
To date, we have hosted two Merck, KGaA, Darmstadt, Germany Access Dialogues:
Merck, KGaA, Darmstadt, Germany Innovative Access and Intellectual Property (IP) Access Dialogue: In our efforts to address the affordability challenge around IP, we hosted this first ever dialogue of its kind gathering together representatives from government, international organizations, research institutions and private sector and explored opportunities for Merck, KGaA, Darmstadt, Germany to join existing innovative platforms such as WIPO Re:Search, DNDi or MPP. Following the meeting, Merck, KGaA, Darmstadt, Germany joined WIPO Re:Search, an open innovation platform sponsored by the World Intellectual Property Organization (WIPO) in collaboration with Bio Ventures for Global Health (BVGH) for the sharing of intellectual property and knowledge to accelerate early discovery for infectious diseases.
For more information on the Merck, KGaA, Darmstadt, Germany Innovative Access and Intellectual Property (IP) Access Dialogue, please click HERE.
For more information on Merck, KGaA, Darmstadt, Germany joining WIPO Re:Search, please click HERE
Access Dialogue on Accessibility / Supply Chain Challenges: Thinking Differently!
Access Dialogue on Accessibility / Supply Chain Challenges: Thinking Differently!: The meeting gathered partners and stakeholders from the health sector and beyond to share cross-industry experiences in improving supply chains to deliver products and solutions to people in developing countries and explore how sectors can work together to achieve the common goal of strengthening the delivery of much-needed products to developing countries. Participants in this initiative include industry partners (eg GSK, Lilly, Sanofi); international organizations (eg Global Fund, UNITAID, World Bank); as well as experts in the field of global health, development and supply chain (eg Global Development Advisors).


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.